China SXT Closes $12M Offering With Zero-Price Warrants and $12M Over-Allotment Option
SXTC is trading near its 52-week low of $0.123 (0.3% below the low) on elevated volume (16× avg).
Summary
China SXT closed a $12M registered direct offering with zero-price exercise warrants that could add up to 72M shares, plus a $12M over-allotment option. Existing ATM and pre-paid advance programs are suspended for 45 days.
Key Events · Financing and Capital Events · SXTC
-
$12M Offering Closed
On October 9, 2026, 8 million units were sold at $1.50 each, raising approximately $12 million before placement agent fees and expenses.
-
Zero-Price Warrant Dilution
The warrants include a zero-price exercise option allowing holders to receive up to 72 million Class A ordinary shares at no additional cost, subject to a $0.50 floor price.
-
$12M Over-Allotment Option
During the 30-day period after closing, investors may purchase up to an additional $12 million of securities on identical terms.
-
Existing Financing Suspended
Per the purchase agreement, the $100M ATM program and the Smart Mart pre-paid advance facility are suspended for 45 days following closing.
Analysis · SXTC · Life Sciences
The $12 million registered direct offering closed on October 9, 2026, with 8 million units issued at $1.50 each. A highly dilutive structure for a company trading near its 52-week low, the warrants carry a zero-price exercise option that could issue up to 72 million additional shares at no cost to holders. Investors also hold a 30-day over-allotment option for another $12 million on identical terms. Simultaneously, the company suspended its existing $100M ATM program and a pre-paid advance facility for 45 days, suggesting the new investors demanded a pause on competing dilution sources.
How filings like this one have moved
In the 30 days to Oct 9, 2026, 36.7% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SXTC was trading at $0.12 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $453.9K. The 52-week trading range was $0.12 to $83,758.24. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.